Involvement of thromboxane a2 in antigen-induced nasal blockage in guinea pigs

International Archives of Allergy and Immunology

Volumn 112, Issue 4, 1997, Pages 400-405

  Yasui, Kiyoshi ^a   Asanuma, Fujio ^a   Furue, Yoko ^a   Arimura, Akinori ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Allergic rhinitis; Intranasal pressure; Nasal blockage; S 1452; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; DIPHENHYDRAMINE; DOMITROBAN; OVALBUMIN; THROMBOXANE A2; THROMBOXANE B2; 7 (3 BENZENESULFONAMIDOBICYCLO[2.2.1]HEPT 2 YL) 5 HEPTENOIC ACID; ANTIGEN; BICYCLO COMPOUND; DRUG DERIVATIVE; HISTAMINE; MONOUNSATURATED FATTY ACID; PROSTAGLANDIN ENDOPEROXIDE;

ANIMAL EXPERIMENT; ARTICLE; GUINEA PIG; MALE; NONHUMAN; NOSE CAVITY; NOSE CONGESTION; NOSE MUCUS; PRIORITY JOURNAL; SENSITIZATION; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; NOSE OBSTRUCTION; PHYSIOLOGY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADMINISTRATION, INHALATION; ANIMALS; ANTIGENS; BICYCLO COMPOUNDS; DIPHENHYDRAMINE; FATTY ACIDS, MONOUNSATURATED; GUINEA PIGS; HISTAMINE; MALE; NASAL OBSTRUCTION; OVALBUMIN; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; THROMBOXANE A2; THROMBOXANE B2;

EID: 0030615258     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237487     Document Type: Article

References (26)

1. Okuda M: The pathophysiology of allergic rhinitis, ACI News 1989;1:167-176.
2. White MV, Kaliner MA: Mediators of allergic rhinitis, J Allergy Clin Immunol 1992;90:699-704.
3. Naclerio RM, Baroody FM: Observations on the response of the nasal mucosa to allergens, Otolaryngol Head Neck Surg 1994:111:355-363.
4. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF Jr., Meyers DA, Norman PS, Lichtenstein LM: Mediator release after nasal airway challenge with allergen, Am Rev Respir Dis 1983;128:597-602.
5. Skoncr DP, Asman B, Fireman P: Effect of chlorpheniramine on airway physiology and symptoms during natural pollen exposure, Am J Rhinol 1994;8:43-48.
6. Wagenmann M, Baroody FM, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM: The effect of terfenadine on unilateral nasal challenge with allergen, J Allergy Clin Immunol 1994;93:594-605.
7. Skoner DP, Doyle WJ, Boehm S, Fireman P: Effect of terfenadine on nasal, eustachian tube, and pulmonary' function after provocative intranasal histamine challenge, Ann Allergy 1991: 67:619-624.
8. Fox CC, Kagey-Sobotka A, Schlcimer RP, Peters SP, MacGlashan DW Jr.: Mediator release from human basophils and mast cells from lung and intestinal mucosa, hit Arch Allergy Appl Immunol 1985:77:130-136.
9. Higgs GA, Moncada S, Salmon JA, Seager K: The source of thromboxane and prostaglandins in experimental inflammation, Br J Pharmacol 1983:79:863-868.
10. Feogh ML, Maddox YT, Ramwell PW: Human peritoneal eosinophils and fonnation of ara-chidonate cyclooxygenase products, Scand J Immunol 1986;23:599-603.
11. Ohtani M, Matsuura T, Watanabe F, Narisada M: Enantioselective synthesis of S-1452. an orally active potent thromboxane Acceptor antagonist, J OrgChem 1991:56:2122-2127.
12. Arita H, Kurosawa A, Oguma T, Kitamura T, Ebihara A, Narisada M: S-1452 - A novel TxA, receptor antagonist, Cardiovasc Drug Rev 1992;10:280-295.
13. Arimura A, Asanuma F, Kurosawa A, Harada M: Antiasthmatic activity of a novel thromboxane A-, antagonist, S-1452. in guinea pigs, Int Arch Allergy Immunol 1992;98:239-246.
14. Arimura A, Asanuma F, Kurosawa A, Harada M: Contribution of thromboxane A to the antigen-induced immediate asthmatic response mediated by IgGl antibody by augmentation of bronchial responsiveness in guinea pigs, Br J Pharmacol 1994;111:339-345.
15. 2 receptor antagonist, S-1452. on antigen-induced sustained bronchial hyperresponsiveness, Eur J Pharmacol 1994; 260:201-209.
16. Brown MS, Stephen PP, Adkinson NF Jr., Proud D, Kagey-Sobotka A, Norman PS, Lichtenstein LM, Naclerio RM: Arachidonic acid metabolites during nasal challenge, Arch Otolaryngol Head Neck Surg 1987:113:179-183.
17. Mizuno H, Kawamura Y, Iwase N, Ohno H: Effects of flutropium on experimental models of drug- and allergy-induced rhinitis in guinea pigs, Jpn J Pharmacol 1991;55:321-328.
18. Raphael GD, Meredith SD, Baraniuk JN, Druce HM, Banks SM, Kaliner MA: The pathophysiology of rhinitis, II, Assessment of the sources of protein in histamine-induced nasal secretions, Am Rev Respir Dis 1989;139:791-800.
19. Koda A, Miura T, Inagaki N, Sakamoto O, Arimura A, Nagai H, Mori H: A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions, Int Arch Allergy Appl Immunol 1990:92:209-216.
20. Lotvall J, Elwood W, Tokuyama K, Sakamoto T, Barnes PJ, Chung KF: A thromboxane mimetic, U-46619. produces plasma exudation in air-waysof the guinea pig, J Appl Physiol 1992;72: 2415-2419.
21. 4 in allergic rhinitis, Ann Allergy 1988;60:537-540.
22. Donnelly AL, Glass M, Minkwitz MC, Casale TB: The leukotriene Dj-receptor antagonist, 1CI 204.219. relieves symptoms of acute seasonal allergic rhinitis, Am J Respir Crit Care Med 1995;151:1734-1739.
23. Knapp HR: Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor, N Engl J Med 1990;323:1745-1748.
24. Doyle WJ, Boehm S, Skoner DP: Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy, J Allergy Clin Immunol 1990;86:924-935.
25. Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM: Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat, Am Rev Respir Dis 1988;137:613-616.
26. Leggieri E, Tedeschi A, Lorini M, Bianco A, Miadonna A: Study of the effects of PAF-aceth-cr on nasal airways, Allergy 1991;46:466-471.